Zomedica Announces Private Placement of Preferred Shares
10 mai 2019 06h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares
26 mars 2019 06h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., March 26, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical...
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares
25 mars 2019 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., March 25, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical...
Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates
05 mars 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., March 05, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, initiated enrollment in its...
Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results
26 févr. 2019 16h05 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs
15 janv. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced the...
Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update
14 janv. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program
20 déc. 2018 17h23 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today provided an update on...
Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform
27 nov. 2018 06h51 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced it has...
Zomedica Announces $10 Million Private Offering of Common Shares
27 nov. 2018 06h50 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...